AstraZeneca steps up push into cancer immunotherapy By: Reuters: Company News July 31, 2014 at 08:51 AM EDT LONDON, July 31 (Reuters) - AstraZeneca is accelerating its push into cancer immunotherapy, with plans to test a key experimental drug in new tumour types. Read More >> Related Stocks: Astrazeneca Plc ADR Bristol-Myers Squibb Merck & Co Pfizer Rogers Corp